Revenue during the quarter grew 5.62 percent to $3,231 million from $3,059 million in the previous year period. Gross margin for the quarter expanded 132 basis points over the previous year period to 48.03 percent. Total expenses were 97.03 percent of quarterly revenues, up from 90.32 percent for the same period last year. That has resulted in a contraction of 671 basis points in operating margin to 2.97 percent.

Operating income for the quarter was $96 million, compared with $296 million in the previous year period.

"We are extremely proud of our accomplishments during our first fiscal year as the 'new' BD," said Vincent A. Forlenza, chairman, chief executive officer and president. "Our solid revenue growth and continued margin expansion allow us to invest in innovation while delivering double-digit increases in earnings. We look forward to fiscal 2017 with confidence as we continue to focus on improving outcomes, expanding access to care, lowering costs and optimizing safety, which will ultimately enrich our purpose of advancing the world of health."

For financial year 2017, Becton, Dickinson and Company forecasts diluted earnings per share to be in the range of $7.23 to $7.33. It forecasts diluted earnings per share to be in the range of $9.45 to $9.55 on adjusted basis for the same period.